Blood Pressure Medication Recalled Over Cancer Risk
Teva Pharmaceuticals has recalled over 580,000 bottles of prazosin hydrochloride capsules due to potentially cancer-causing nitrosamine impurities. The U.S. FDA classifies this as a Class II risk, meaning adverse health effects are possible but serious consequences are unlikely. Consumers are advised to check their medication and consult their doctor if affected.
Teva Pharmaceuticals has issued a voluntary recall of more than 580,000 bottles of prazosin hydrochloride capsules, a medication commonly used to treat high blood pressure and PTSD-related nightmares. The recall was prompted by tests showing elevated levels of nitrosamine impurities, specifically No-nitroso Prazosin impurity C, which are considered potentially carcinogenic. The U.S. Food and Drug Administration has classified the recall as Class II, indicating that while use of the affected product may cause temporary or reversible adverse health effects, the likelihood of serious consequences is remote. The recall includes multiple strengths of the medication: 1 mg, 2 mg, and 5 mg capsules. Consumers are urged to check their medicine bottles for the affected lots and consult their healthcare provider for further instructions. The FDA has not provided specific disposal instructions but recommends contacting a doctor for guidance.
